TAMARA GORDON: Open Payments
NPI 1083219471 · AMITYVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 47 payments from 8 companies in 2025. Trend: 2023 $1,451 · 2024 $970 · 2025 $1,349
Food & beverage: $1,337Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $384 |
| Alkermes, Inc. | 9 | $365 |
| Supernus Pharmaceuticals, Inc. | 5 | $223 |
| ABBVIE INC. | 4 | $187 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: CAPLYTA, LYBALVI, Qelbree, VRAYLAR, INGREZZA, FANAPT, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
